Literature DB >> 6096231

Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia.

U Rosing, K Carlström.   

Abstract

Peripheral serum levels of unconjugated (E1) and total (tE1) oestrone, unconjugated oestradiol-17 beta, unconjugated (E3) and total (tE3) oestriol, progesterone, unconjugated dehydroepiandrosterone (DHA) and dehydroepiandrosterone sulphate (DHAS), and urinary tE3 excretion were determined in pre-eclamptic patients at gestational weeks 32 and 36 and in women with normal pregnancy at the corresponding length of gestation. DHA and DHAS were also analyzed in samples taken 6 weeks after delivery. There were no differences between pre-eclamptic and normal subjects in unconjugated oestrogens and progesterone. Serum tE1 and tE3 levels and urinary tE3 were significantly lower, and the E1/tE1 and E3/tE3 ratios significantly higher in the pre-eclampsia patients. Serum DNA and the DHA/DHAS ratio were significantly elevated in the pre-eclampsia patients during pregnancy, while no differences in these respects were found in the samples taken 6 weeks after delivery. There were no differences in serum DHAS levels. The findings are thought to reflect a general decrease in fetoplacental oestrogen production in combination with a reduced hepatic steroid conjugation in pre-eclamptic subjects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6096231     DOI: 10.1159/000299081

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Perinatal characteristics in relation to incidence of and mortality from prostate cancer.

Authors:  A Ekbom; C C Hsieh; L Lipworth; A Wolk; J Pontén; H O Adami; D Trichopoulos
Journal:  BMJ       Date:  1996-08-10

Review 2.  Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature.

Authors:  Sarah Nechuta; Nigel Paneth; Ellen M Velie
Journal:  Cancer Causes Control       Date:  2010-03-12       Impact factor: 2.506

3.  Estrogen synthesis genes CYP19A1, HSD3B1, and HSD3B2 in hypertensive disorders of pregnancy.

Authors:  Masanori Shimodaira; Tomohiro Nakayama; Ichiro Sato; Naoyuki Sato; Noriko Izawa; Yoshihiro Mizutani; Kiyohide Furuya; Tatsuo Yamamoto
Journal:  Endocrine       Date:  2012-05-26       Impact factor: 3.633

4.  O-methylation of catechol estrogens by human placental catechol-o-methyltransferase: interindividual differences in sensitivity to heat inactivation and to inhibition by dietary polyphenols.

Authors:  Bao Ting Zhu; Karen Y Wu; Pan Wang; May Xiaoxin Cai; Allan H Conney
Journal:  Drug Metab Dispos       Date:  2010-07-06       Impact factor: 3.922

Review 5.  Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia.

Authors:  D S Boeldt; I M Bird
Journal:  J Endocrinol       Date:  2016-10-11       Impact factor: 4.286

Review 6.  Examining breast cancer growth and lifestyle risk factors: early life, childhood, and adolescence.

Authors:  Elizabeth H Ruder; Joanne F Dorgan; Sibylle Kranz; Penny M Kris-Etherton; Terryl J Hartman
Journal:  Clin Breast Cancer       Date:  2008-08       Impact factor: 3.225

Review 7.  Androgens in maternal vascular and placental function: implications for preeclampsia pathogenesis

Authors:  Sathish Kumar; Geoffrey H Gordon; David H Abbott; Jay S Mishra
Journal:  Reproduction       Date:  2018-10-16       Impact factor: 3.906

8.  Effects of estradiol on HIF-1α expression and trophoblast differentiation in first trimester villous explant cultures.

Authors:  Geum Joon Cho; Lyn Hwa Lee; Bona Lee; Jaeeun Lee; Ki-Hoon Ahn; Soon-Cheol Hong; Hai-Joong Kim; Min-Jeong Oh
Journal:  Obstet Gynecol Sci       Date:  2017-12-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.